Minesh Mehta, is a world-renowned expert in radiation oncology, proton therapy, radiosurgery, brain tumors, and cancer research. He is Deputy Director and Chief of Radiation Oncology at Miami Cancer Institute, and Professor and Chair of Radiation Oncology at Florida International University, where he oversees one of the world’s most comprehensive radiation therapy programs, including South Florida’s first Proton Therapy Center and a comprehensive suite of the most sophisticated radiation technologies.
He came to MCI from the University of Maryland’s Proton Treatment Center, where, as Medical Director, he launched the mid-Atlantic’s first proton treatment center. As Chairman of the University of Wisconsin’s Department of Human Oncology, he led numerous research studies, fostered technology innovation through federally-funded grants (Tomotherapy PO1), was Program Leader for the UWCCC’s Imaging and Radiation Sciences Program (P30), led a project grant (U01) in brain tumors, and has been Chair of the RTOG/NRG Oncology’s Brain Tumor Committee since 1999, funded by NIH CA RTOG and NRG grants.
He has led several national/international clinical studies, receiving NIH, and industry grants and has been awarded many honors. He has held leadership positions in ABR, ABS, ASTRO, ASCO, CCG, ECOG, FDA Radiological Devices Panel, NAPT, PCG, PTCOG, SNO, etc.
A well-respected clinician, educator, and researcher, he has over a thousand publications (manuscripts, book chapters, abstracts), and serves on the boards of several journals.
He graduated with honors from the University of Zambia School of Medicine and completed his residency at UW, where he was chief resident in radiation oncology.
Disclosures:
- Employment: Florida International University:Chair and Professor:Employee;Miami Cancer Institute / Baptist Health South Florida:Chief of Radiation Oncology:Employee
- Compensation: Mevion: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: To Present ;PCG - The Proton Collaborative Group: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: To Present ;The National Association for Proton Therapy - NAPT: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: To Present ;AIQ: Consultant, Compensation Payment-End Date: To Present ;BDT: Consultant, Compensation Payment-End Date: 12/01/2025 ;Ch
- Ownership: none
- Leadership: Florida International University:Professor and Chair;Mevion Technological Advisory Board:Advisory Board;Miami Cancer Institute:Deputy Director and Chief of Radiation Oncology;NAPT Board Member (National Association for Proton Therapy):Board Member;NRG Oncology Board Member:Board Member;PCG Board Member (Proton Collaborative Group):Board Member